Moderna Prepping Newly Approved MRNA Flu Vaccine For 2026-27 Respiratory Virus Season
The shot, initially approved for people 50-64, "will allow us to rapidly adjust to rapidly emerging new flu strains, a capacity we have not had before,” said Dr. Georges C. Benjamin of the American Public Health Association.